Thompson D, et al
TL;DR: Adding 2mL of bacteriostatic water to a 5mg BPC-157 vial creates a concentration of 2,500 mcg/mL, ideal for accurate dosing
BPC-157: gastrointestinal-protection research in models of ulcerative damage, inflammatory bowel disease and short-bowel syndrome
Recuperative herbal formula jing si maintains vasculature permeability balance, regulates inflammation and assuages concomitants of long-covid
According to the FDAs website, Compounding is generally a practice in which a licensed pharmacist, a licensed physician, or, in the case of an outsourcing facility, a person under the supervision of a licensed pharmacist, combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient. This is referring to a 503A or lesser designated compounding pharmacy where compounds are created for patient-specific prescriptions and not for mass production
We also thank Johanna Welch, PhD, and Angela Harper, PhD, who provided medical writing services on behalf of Novo Nordisk A/S